Foster R S, Baniel J, Leibovitch I, Curran M, Bihrle R, Rowland R, Donohue J P
Department of Urology, Indiana University Medical Center, Indianapolis, USA.
J Urol. 1996 Jun;155(6):1943-5.
We determined whether teratomatous elements in the orchiectomy specimen predict for teratoma in the retroperitoneum in patients who have not received chemotherapy.
We retrospectively reviewed the records of patients with clinical stages A, B and B2 nonseminoma who underwent retroperitoneal lymph node dissection.
Teratomatous elements in the orchiectomy specimen predict for retroperitoneal teratoma.
When deciding on treatment for low stage nonseminoma, the presence or absence of teratoma in the orchiectomy specimen should be considered to minimize double therapy.
我们确定了在未接受化疗的患者中，睾丸切除标本中的畸胎瘤成分是否可预测腹膜后的畸胎瘤。
我们回顾性分析了接受腹膜后淋巴结清扫术的临床分期为A、B和B2期非精原细胞瘤患者的记录。
睾丸切除标本中的畸胎瘤成分可预测腹膜后畸胎瘤。
在决定低分期非精原细胞瘤的治疗方案时，应考虑睾丸切除标本中是否存在畸胎瘤，以尽量减少双重治疗。
